A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Age
18–35
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female subjects aged 18-35 years
Not engaged in regular lower extremity fitness activities in the past 6 months prior to screening
Willing to refrain from use of ice, heat and massage during the study
DOMS score ≥4 Pain at Rest (PAR) and a DOMS score ≥5 Pain on Walking (POW), with moderate or severe on categorical scale
You may not be if
Pain medication \& corticosteroids prior to randomization
Topical analgesic or anti-inflammatory treatment over the previous month
Body mass index of \>32 kg/m2
Clareo Health | A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness
